Spine Top Stories Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years byJosh SandbergMay 31, 2022
Spine Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis byJosh SandbergApril 21, 2022
Spine Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS byJosh SandbergMay 13, 2021
Biologics Regulatory Cerapedics Announces FDA approval of an IDE supplement byJosh SandbergJuly 22, 2020
Spine Top Stories New long-term data on the effect of lumbar total disc replacement on adjacent level degeneration reinforces outcomes from previous studies byJosh SandbergMay 8, 2017
Hospitals BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study with CERAMENT™G byJosh SandbergAugust 10, 2016
Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
Hospitals Neuro Spine Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8® byJosh SandbergJune 9, 2015
